Gnosis Health

Gnosis Health, a spinout from Newcastle and Plymouth universities, has successfully secured £1.1 million in a recent funding round. This capital infusion is earmarked to advance the development and market launch of MAXine, its innovative AI-powered digital healthcare assistant specifically designed for Parkinson's disease management.

Summary of transaction details:

• Value: £1.1 million
• Sector: Healthcare & Biotech
• Advisor: Not mentioned
• Key Entities: Target: Gnosis Health; Investors: Innovate UK, SFC Capital, Northstar Ventures
• Location: UK (implied by Newcastle/Plymouth universities, Innovate UK, North East NHS pilots)

Note: This funding round will enable Gnosis Health to expand its engineering capabilities, complete critical NHS pilots, and accelerate the commercial debut of MAXine, addressing a significant clinical need for continuous, adaptive monitoring in Parkinson's care through advanced AI and wearable integration.